Research Article
Effect and Potential Mechanism of Electroacupuncture Add-On Treatment in Patients with Parkinson’s Disease
Table 5
Changes in the levels of neuroinflammatory factors and neurotransmitters in serum in the D + EA and D groups.
| | D + EA group (after and before EA) | D group (after and before 2 months) | |
| Neuroinflammatory factors | | | | NO [mmol/L, median (quartile)] | 53.181 (6.421~64.505) | 80.494 (62.154~107.569) | 0.003 | IL-1β [pg/mL, median (quartile)] | 2.083 (−0.938~5.337) | 2.525 (−3.358~4.034) | 0.425 | PGE2 [pg/mL, median (quartile)] | 1.373 (−35.700~6.699) | 1.436 (−2.378~6.738) | 0.215 | TNF-α [pg/mL, median (quartile)] | 8.643 (−22.139~62.882) | 20.537 (−17.089~52.414) | 0.773 | Neurotransmitters | | | | NE [μg/mL, median (quartile)] | 1.234 (0.734~1.512) | 1.208 (0.609~1.878) | 0.808 | Ach [nmol/L, median (quartile)] | 0.007 (0.002~0.011) | 0.008 (0.003~0.015) | 0.603 | DA [μg/mL, median (quartile)] | 1.429 (0.518~3.035) | 1.795 (1.161~2.683) | 0.764 | 5-HT [μg/mL, median (quartile)] | 0.077 (−0.294~0.506) | 0.703 (0.109~0.981) | 0.055 |
|
|
Values are median (lower quartile, upper quartile) for the Kruskal-Wallis test. .
|